Related references
Note: Only part of the references are listed.Equol Enhances Apoptosis-inducing Activity of Genistein by Increasing Bax/Bcl-xL Expression Ratio in MCF-7 Human Breast Cancer Cells
Misaki Ono et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2017)
Daidzein inhibits choriocarcinoma proliferation by arresting cell cycle at G1 phase through suppressing ERK pathway in vitro and in vivo
Wei Zheng et al.
ONCOLOGY REPORTS (2017)
Soy Isoflavones and Breast Cancer Cell Lines: Molecular Mechanisms and Future Perspectives
Alina Uifalean et al.
MOLECULES (2016)
p21(WAF1) Mediates Cell-Cycle Inhibition, Relevant to Cancer Suppression and Therapy
Wafik S. El-Deiry
CANCER RESEARCH (2016)
S-equol, a Secondary Metabolite of Natural Anticancer Isoflavone Daidzein, Inhibits Prostate Cancer Growth In Vitro and In Vivo, Though Activating the Akt/FOXO3a Pathway
Zongliang Lu et al.
CURRENT CANCER DRUG TARGETS (2016)
Equol inhibits proliferation of human gastric carcinoma cells via modulating Akt pathway
Zhi-Ping Yang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Genistein, a soy phytoestrogen, prevents the growth of BG-1 ovarian cancer cells induced by 17β-estradiol or bisphenol A via the inhibition of cell cycle progression
Kyung-A Hwang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Genistein induces G2/M cell cycle arrest and apoptosis via ATM/p53-dependent pathway in human colon cancer cells
Zhiyu Zhang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Current Status of Src Inhibitors in Solid Tumor Malignancies
Lauren N. Puls et al.
ONCOLOGIST (2011)
Equol: History, Chemistry, and Formation
Kenneth D. R. Setchell et al.
JOURNAL OF NUTRITION (2010)
p21 and p27: roles in carcinogenesis and drug resistance
Abde M. Abukhdeir et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2008)
Plasma isoflavone level and subsequent risk of breast cancer among Japanese women: A nested case-control study from the Japan public health center-based prospective study group
Motoki Iwasaki et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Daidzein causes cell cycle arrest at the G1 and G2/M phases in human breast cancer MCF-7 and MDA-MB-453 cells
Eun Jeong Choi et al.
PHYTOMEDICINE (2008)
Activated Src and Ras induce gefitinib resistance by activation of signaling pathways downstream of epidermal growth factor receptor in human gallbladder adenocarcinoma cells
Baoli Qin et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Suppression of anoikis by v-Src but not by activated c-H-Ras in human gallbladder epithelial cells
C Hisano et al.
CELL BIOLOGY INTERNATIONAL (2003)
Role of Src expression and activation in human cancer
RB Irby et al.
ONCOGENE (2000)
p53-independent induction of p21 (WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells
YH Choi et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2000)
Share Paper
